查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442911

放射免疫分析 (RIA) - 全球市場回顧、競爭格局、市場預測 (2030)

Radioimmunoassay (RIA) - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球放射免疫分析（RIA）市場規模預計到2023年將達到5.2398億美元，到2030年將達到6.6031億美元，2024-2030年預測期間複合年增長率為3.36%。放射免疫分析（RIA）的需求主要是由癌症、傳染病等盛行率的增加、流行病和大流行病發生率的增加以及健康意識的提高所驅動。此外，市場預計將受益於該領域眾多正在進行的研究活動、醫療保健提供者和研究人員、行業參與者、戰略合作夥伴之間的合作等，從而為2024-2030 年預測期內市場的整體增長做出貢獻。預計將做出貢獻。

放射免疫分析 (RIA) 市場動態

根據International Agency for Research on Cancer進行的一項研究，2020 年全球估計報告了 1,930 萬新癌症病例。

根據世界衛生組織（WHO）數據顯示，2020年，乳癌226萬例，肺癌221萬例，大腸直腸癌193萬例，攝護腺癌141萬例，胃癌109萬例。被通報。

癌症發生率的增加需要早期有效的診斷，這可以透過使用放射免疫分析（RIA）來實現。放射免疫分析 (RIA) 已被證明對於大腸直腸癌和胰腺癌等癌症的早期檢測極為重要。

此外，根據世界衛生組織 (WHO) (2022) 的數據，2020 年全球約有 3,770 萬人感染人類免疫缺乏病毒 (HIV)。根據世界衛生組織2023年數據，2022年全球約有1,000萬人罹患結核病。這項估計表明，傳染病的盛行率正在上升，增加了對放射免疫分析 (RIA) 進行有效診斷的需求。

然而，放射性材料的使用、對先進實驗室設施的需求以及與使用放射免疫分析（RIA）與其他診斷工具和方法相結合相關的限制等多種限制因素可能對整個放射免疫分析（RIA）市場做出了貢獻。抑制生長。

放射免疫分析（RIA）市場細分分析

依放射免疫分析 (RIA) 市場的產品類型劃分，分析儀預計將在 2023 年佔重要的收入佔有率。

這可以歸因於世界各地傳染病和流行病發病率的不斷上升，以及肝炎等傳染病的高盛行率。

根據世界衛生組織（2022）的數據，2020年全球約有2.41億人感染瘧疾。

根據世界衛生組織（2021）數據，全球每天約有100萬人感染性傳染病。此外，根據相同數據，估計2020年約有1.29億例衣原體病例、710萬例梅毒病例、8,200萬例淋病病例和約1.56億例滴蟲病例。

根據美國疾病管制與預防中心 (2021) 的數據，根據世界衛生組織的估計，2019 年全球約有 2.96 億人患有B型肝炎，5,800 萬人患有C型肝炎。

放射免疫分析儀（RIA）用於識別和檢測樣本中特定物質的濃度，可以進行多種測試。該分析儀更加可靠，並具有直覺的介面和易於使用的功能。

因此，由於上述因素，分析儀類別預計將顯著成長，從而推動整個放射免疫分析（RIA）市場在預測期內的成長。

預計北美將主導整個放射免疫分析 (RIA) 市場。

根據美國疾病管制與預防中心 (2022) 的數據，2019 年美國估計有約 1,189,700 名 13 歲及以上的人感染愛滋病毒。根據美國疾病管制與預防中心 (CDC) (2022) 的數據，2019 年報告了大約 1,752,735 例新癌症病例。

本報告提供了全球放射免疫分析 (RIA) 市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章 放射免疫分析（RIA）市場報告簡介

第二章放射免疫分析（RIA）市場概要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章放射免疫分析（RIA）市場關鍵因素分析

  • 放射免疫分析（RIA）市場的驅動因素
  • 放射免疫分析（RIA）市場的限制與挑戰
  • 放射免疫分析 (RIA) 市場機會

第五章放射免疫分析（RIA）市場的波特五力分析

第六章 放射免疫分析（RIA）市場佈局

  • 產品類別
    • 分析儀
    • 試劑/試劑盒
  • 依用途
    • 研究
    • 臨床診斷
  • 依最終用戶
    • 醫院
    • 臨床診斷實驗室
    • 製藥業
    • 其他
  • 區域
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第 7 章. 放射免疫分析 (RIA) 市場公司與產品概況

  • DIAsource
  • Danaher Corporation
  • Tecan Trading AG
  • Merck KGaA
  • MP BIOMEDICALS
  • Svar Life Science
  • Institute of Isotopes Co. Ltd.
  • PerkinElmer Inc.

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明，聯絡我們

Product Code: DIMDCL0697

The Radioimmunoassay (RIA) Market By Product Type (Analyzers And Reagents & Kits), Application (Research And Clinical Diagnostics), End-User (Hospitals, Clinical Diagnostic Laboratories, Pharmaceutical Industries, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing number of people with infectious diseases and increasing research and development activities

The global Radioimmunoassay (RIA) market was valued at USD 523.98 million in 2023, growing at a CAGR of 3.36% during the forecast period from 2024 to 2030 to reach USD 660.31 million by 2030. The demand for radioimmunoassay is primarily being boosted by the growing prevalence of cancer, infectious diseases, and others, rising incidences of epidemics and pandemics coupled with growing awareness of health. Furthermore, the radioimmunoassay market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the radioimmunoassay market during the forecast period from 2024-2030.

Radioimmunoassay (RIA) Market Dynamics:

The study conducted by the International Agency for Research on Cancer mentioned that worldwide, an estimated 19.3 million new cancer cases were reported in 2020.

According to the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

The increasing burden of cancer necessitates its early and effective diagnosis which can be possible via the usage of radioimmunoassay. Radioimmunoassay is found to be crucial for detecting the early stages of cancer of the colon and pancreas among others.

Also, according to the World Health Organization (WHO) 2022, globally around 37.7 million people suffered from human immunodeficiency virus (HIV) in the year 2020. As per the 2023 data provided by WHO, globally around 10 million people suffered from tuberculosis in 2022. The estimates suggest that the prevalence of infectious diseases is on the rise and will increase the demand for radioimmunoassay for its effective diagnosis.

However, several limitations such as the use of radioactive substances, the need for advanced lab facilities, and others associated with the use of radioimmunoassay coupled with other diagnostic tools and methods may restrict the growth of the overall radioimmunoassay market.

Radioimmunoassay (RIA) Market Segment Analysis:

Radioimmunoassay Market by Product Type (Analyzers and Reagents & Kits), Application (Research and Clinical Diagnostics), End-User (Hospitals, Clinical Diagnostic Laboratories, Pharmaceutical Industries, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type of the radioimmunoassay market, the analyzers, category is expected to amass a significant revenue share in the year 2023.

This can be ascribed to the high incidence of infectious diseases, including hepatitis, and others along with rising incidences of epidemics and pandemics across the globe.

As per the data provided by the WHO 2022, globally around 241 million people suffered from malaria in 2020.

The WHO 2021 data mentioned that, worldwide around 1 million people acquire STDs every day. Also, as per the same source, it was estimated that there were around 129 million cases of chlamydia, 7.1 million cases of syphilis, 82 million cases of gonorrhea, and around 156 million cases of trichomoniasis recorded in the year 2020.

As per Centers for Disease Control and Prevention 2021 based on WHO estimates, in 2019 about 296 million people worldwide were living with hepatitis B, and 58 million people worldwide had hepatitis C.

Radioimmunoassay analyzers can be used to identify and detect the concentration of specific substances in a sample and can perform a variety of tests. The analyzers offer improved reliability, have intuitive interfaces and easy-to-use features.

Therefore, owing to the above-mentioned factors, the analyzers category is expected to register significant growth, thereby driving the growth of the overall radioimmunoassay market during the forecast period.

North America is expected to dominate the overall Radioimmunoassay (RIA) Market:

Among all the regions, North America is estimated to account for the largest share of the Radioimmunoassay market in the year 2023. This can be ascribed to the presence of a large patient pool associated with Sexually transmitted diseases (STSs), cancer, and others, a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

According to the Centers for Disease Control and Prevention 2022, it was estimated that around 1,189,700 people aged 13 and above had HIV in the US in 2019. As per the Centers for Disease Control and Prevention (CDC) (2022), around 1,752,735 new cancer cases were reported in 2019.

As per the American Thyroid Association 2019, around 20 million people in America have some form of thyroid disease, and an estimated 12 percent or more of American people will develop thyroid disease during their lifetime.

Moreover, as per the US Department of Health and Human Services (HHS) press release in the year 2021, the US government had invested USD 650 million in rapid diagnostic testing in the latest action to increase access to tests.

Thus, the above-mentioned factors are likely to propel the growth of the Radioimmunoassay market in the region during the forecast period from 2024-2030.

Radioimmunoassay (RIA) Market Key Players:

Some of the key market players operating in the Radioimmunoassay market include DIAsource, MP BIOMEDICALS, Merck KGaA, Tecan Trading AG, Svar Life Science, Institute of Isotopes Co. Ltd., PerkinElmer Inc., Danaher Corporation, and Others.

Key Takeaways from the Radioimmunoassay (RIA) Market Report Study

  • Market size analysis for current Radioimmunoassay market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Radioimmunoassay market.
  • Various opportunities available for the other competitors in the Radioimmunoassay market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Radioimmunoassay market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Radioimmunoassay market growth in the coming future?

Target Audience who can be benefited from this Radioimmunoassay (RIA) Market Report Study

  • Radioimmunoassay product providers
  • Research organizations and consulting companies
  • Radioimmunoassay-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in radioimmunoassays
  • Various End-users who want to know more about the radioimmunoassay market and the latest developments in the radioimmunoassay market.

Frequently Asked Questions for the Radioimmunoassay (RIA) Market:

1. What is radioimmunoassay?

Radioimmunoassay is for determining antibody levels by introducing an antigen labeled with a radioisotope and measuring the subsequent radioactivity of the antibody component.

2. What is the market for global radioimmunoassay?

The global Radioimmunoassay (RIA) market was valued at USD 523.98 million in 2023, growing at a CAGR of 3.36% during the forecast period from 2024 to 2030 to reach USD 660.31 million by 2030.

3. What are the drivers for the global radioimmunoassay market?

The demand for radioimmunoassay is primarily being boosted by the growing prevalence of cancer, infectious diseases, and others, rising incidences of epidemics and pandemics coupled with growing health awareness. Furthermore, the radioimmunoassay market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the radioimmunoassay market during the forecast period from 2024-2030.

4. Who are the key players operating in the global radioimmunoassay market?

Some of the key market players operating in the radioimmunoassay market include DIAsource, MP BIOMEDICALS, Merck KGaA, Tecan Trading AG, Svar Life Science, Institute of Isotopes Co. Ltd., PerkinElmer Inc., Danaher Corporation, and Others.

5. Which region has the highest share in the radioimmunoassay market?

North America is expected to dominate the overall radioimmunoassay market during the forecast period from 2024-2030. Owing to the significance of key growth factors such as the presence of a large patient pool associated with Sexually transmitted diseases (STSs), cancer, and others, a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1. Radioimmunoassay Market Report Introduction

2. Radioimmunoassay Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Radioimmunoassay Market Key Factors Analysis

  • 4.1. Radioimmunoassay Market Drivers
    • 4.1.1. Increasing prevalence of infectious diseases such as tuberculosis, Hepatitis B, and others
    • 4.1.2. Increasing incidences of epidemics and pandemics
    • 4.1.3. Increasing awareness of health
  • 4.2. Radioimmunoassay Market Restraints and Challenges
    • 4.2.1. Availability of alternative diagnostic tools and methods
    • 4.2.2. Limitations associated with radioimmunoassay
  • 4.3. Radioimmunoassay Market Opportunities
    • 4.3.1. Growing need to improve the safety and accuracy of radioimmunoassay

5. Radioimmunoassay Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Radioimmunoassay Market Layout

  • 6.1. By Product Type
    • 6.1.1. Analyzers
    • 6.1.2. Reagents & Kits
  • 6.2. By Application
    • 6.2.1. Research
    • 6.2.2. Clinical Diagnostics
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Clinical Diagnostic Laboratories
    • 6.3.3. Pharmaceutical Industries
    • 6.3.4. Others
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.3.3. India Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Radioimmunoassay Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Radioimmunoassay Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Radioimmunoassay Market Size in USD million (2021-2030)

7. Radioimmunoassay Market Company and Product Profiles

  • 7.1. DIAsource
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Danaher Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Tecan Trading AG
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Merck KGaA
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. MP BIOMEDICALS
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Svar Life Science
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Institute of Isotopes Co. Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. PerkinElmer Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Radioimmunoassay Market in Global (2021-2030)
  • Table 3: Radioimmunoassay Market in Global by Product Type (2021-2030)
  • Table 4: Radioimmunoassay Market in Global by Application (2021-2030)
  • Table 5: Radioimmunoassay Market in Global by End-User (2021-2030)
  • Table 6: Radioimmunoassay Market in Global by Geography (2021-2030)
  • Table 7: Radioimmunoassay Market in North America (2021-2030)
  • Table 8: Radioimmunoassay Market in the US (2021-2030)
  • Table 9: Radioimmunoassay Market in Canada (2021-2030)
  • Table 10: Radioimmunoassay Market in Mexico (2021-2030)
  • Table 11: Radioimmunoassay Market in Europe (2021-2030)
  • Table 12: Radioimmunoassay Market in France (2021-2030)
  • Table 13: Radioimmunoassay Market in Germany (2021-2030)
  • Table 14: Radioimmunoassay Market in the United Kingdom (2021-2030)
  • Table 15: Radioimmunoassay Market in Italy (2021-2030)
  • Table 16: Radioimmunoassay Market in Spain (2021-2030)
  • Table 17: Radioimmunoassay Market in the Rest of Europe (2021-2030)
  • Table 18: Radioimmunoassay Market in Asia-Pacific (2021-2030)
  • Table 19: Radioimmunoassay Market in China (2021-2030)
  • Table 20: Radioimmunoassay Market in Japan (2021-2030)
  • Table 21: Radioimmunoassay Market in India (2021-2030)
  • Table 22: Radioimmunoassay Market in Australia (2021-2030)
  • Table 23: Radioimmunoassay Market in South Korea (2021-2030)
  • Table 24: Radioimmunoassay Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Radioimmunoassay Market in the Rest of the World (2021-2030)
  • Table 26: Radioimmunoassay Market in the Middle East (2021-2030)
  • Table 27: Radioimmunoassay Market in Africa (2021-2030)
  • Table 28: Radioimmunoassay Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Radioimmunoassay Market in Global (2021-2030)
  • Figure 3: Radioimmunoassay Market in Global by Product Type (2021-2030)
  • Figure 4: Radioimmunoassay Market in Global by Application (2021-2030)
  • Figure 5: Radioimmunoassay Market in Global by End-User (2021-2030)
  • Figure 6: Radioimmunoassay Market in Global by Geography (2021-2030)
  • Figure 7: Radioimmunoassay Market in North America (2021-2030)
  • Figure 8: Radioimmunoassay Market in the US (2021-2030)
  • Figure 9: Radioimmunoassay Market in Canada (2021-2030)
  • Figure 10: Radioimmunoassay Market in Mexico (2021-2030)
  • Figure 11: Radioimmunoassay Market in Europe (2021-2030)
  • Figure 12: Radioimmunoassay Market in France (2021-2030)
  • Figure 13: Radioimmunoassay Market in Germany (2021-2030)
  • Figure 14: Radioimmunoassay Market in the United Kingdom (2021-2030)
  • Figure 15: Radioimmunoassay Market in Italy (2021-2030)
  • Figure 16: Radioimmunoassay Market in Spain (2021-2030)
  • Figure 17: Radioimmunoassay Market in the Rest of Europe (2021-2030)
  • Figure 18: Radioimmunoassay Market in Asia-Pacific (2021-2030)
  • Figure 19: Radioimmunoassay Market in China (2021-2030)
  • Figure 20: Radioimmunoassay Market in Japan (2021-2030)
  • Figure 21: Radioimmunoassay Market in India (2021-2030)
  • Figure 22: Radioimmunoassay Market in Australia (2021-2030)
  • Figure 23: Radioimmunoassay Market in South Korea (2021-2030)
  • Figure 24: Radioimmunoassay Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Radioimmunoassay Market in the Rest of the World (2021-2030)
  • Figure 26: Radioimmunoassay Market in the Middle East (2021-2030)
  • Figure 27: Radioimmunoassay Market in Africa (2021-2030)
  • Figure 28: Radioimmunoassay Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis